281 related articles for article (PubMed ID: 26542160)
1. Direct medical costs attributable to type 2 diabetes mellitus: a population-based study in Catalonia, Spain.
Mata-Cases M; Casajuana M; Franch-Nadal J; Casellas A; Castell C; Vinagre I; Mauricio D; Bolíbar B
Eur J Health Econ; 2016 Nov; 17(8):1001-1010. PubMed ID: 26542160
[TBL] [Abstract][Full Text] [Related]
2. Large impact of antidiabetic drug treatment and hospitalizations on economic burden of diabetes mellitus in The Netherlands during 2000 to 2004.
van der Linden MW; Plat AW; Erkens JA; Emneus M; Herings RM
Value Health; 2009 Sep; 12(6):909-14. PubMed ID: 19508664
[TBL] [Abstract][Full Text] [Related]
3. [Costs of known diabetes mellitus in Spain].
Hart WM; Espinosa C; Rovira J
Med Clin (Barc); 1997 Sep; 109(8):289-93. PubMed ID: 9379750
[TBL] [Abstract][Full Text] [Related]
4. Major complications have an impact on total annual medical cost of diabetes: results of a database analysis.
Morsanutto A; Berto P; Lopatriello S; Gelisio R; Voinovich D; Cippo PP; Mantovani LG
J Diabetes Complications; 2006; 20(3):163-9. PubMed ID: 16632236
[TBL] [Abstract][Full Text] [Related]
5. Direct cost of patients with type 2 diabetes mellitus healthcare and its complications in Lithuania.
Domeikienė A; Vaivadaitė J; Ivanauskienė R; Padaiga Ž
Medicina (Kaunas); 2014; 50(1):54-60. PubMed ID: 25060205
[TBL] [Abstract][Full Text] [Related]
6. Cost of diabetes: comparison of disease-attributable and matched cohort cost estimation methods.
Tunceli O; Wade R; Gu T; Bouchard JR; Aagren M; Luo W
Curr Med Res Opin; 2010 Aug; 26(8):1827-34. PubMed ID: 20491613
[TBL] [Abstract][Full Text] [Related]
7. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
[TBL] [Abstract][Full Text] [Related]
8. Empiric investigation on direct costs-of-illness and healthcare utilization of Medicaid patients with diabetes mellitus.
Guo JJ; Gibson JT; Gropper DM; Oswald SL; Barker KN
Am J Manag Care; 1998 Oct; 4(10):1433-46. PubMed ID: 10338736
[TBL] [Abstract][Full Text] [Related]
9. Lifetime direct medical costs of treating type 2 diabetes and diabetic complications.
Zhuo X; Zhang P; Hoerger TJ
Am J Prev Med; 2013 Sep; 45(3):253-61. PubMed ID: 23953350
[TBL] [Abstract][Full Text] [Related]
10. Direct costs in diabetic and non diabetic people: the population-based Turin study, Italy.
Bruno G; Picariello R; Petrelli A; Panero F; Costa G; Cavallo-Perin P; Demaria M; Gnavi R
Nutr Metab Cardiovasc Dis; 2012 Aug; 22(8):684-90. PubMed ID: 21907553
[TBL] [Abstract][Full Text] [Related]
11. The costs of type 2 diabetes mellitus outpatient care in the Brazilian public health system.
Bahia LR; Araujo DV; Schaan BD; Dib SA; Negrato CA; Leão MP; Ramos AJ; Forti AC; Gomes MB; Foss MC; Monteiro RA; Sartorelli D; Franco LJ
Value Health; 2011; 14(5 Suppl 1):S137-40. PubMed ID: 21839888
[TBL] [Abstract][Full Text] [Related]
12. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
[TBL] [Abstract][Full Text] [Related]
13. Trend and factors associated with healthcare use and costs in type 2 diabetes mellitus: a decade experience of a universal health insurance program.
Cheng JS; Tsai WC; Lin CL; Chen L; Lang HC; Hsieh HM; Shin SJ; Chen T; Huang CT; Hsu CC
Med Care; 2015 Feb; 53(2):116-24. PubMed ID: 25517075
[TBL] [Abstract][Full Text] [Related]
14. Comparison of direct costs of type 2 diabetes care: different care models with different outcomes.
Giorda CB; Picariello R; Nada E; Tartaglino B; Marafetti L; Costa G; Petrelli A; Gnavi R
Nutr Metab Cardiovasc Dis; 2014 Jul; 24(7):717-24. PubMed ID: 24598600
[TBL] [Abstract][Full Text] [Related]
15. The economic burden of nephropathy in diabetic patients in Germany in 2002.
Happich M; Landgraf R; Piehlmeier W; Falkenstein P; Stamenitis S
Diabetes Res Clin Pract; 2008 Apr; 80(1):34-9. PubMed ID: 18187227
[TBL] [Abstract][Full Text] [Related]
16. [Cost of diabetes mellitus in Spain].
González P; Faure E; Del Castillo A;
Med Clin (Barc); 2006 Nov; 127(20):776-84. PubMed ID: 17198665
[No Abstract] [Full Text] [Related]
17. Changes in prevalence of diabetic complications and associated healthcare costs during a 10-year follow-up period among a nationwide diabetic cohort.
Chen HL; Hsu WW; Hsiao FY
J Diabetes Complications; 2015; 29(4):523-8. PubMed ID: 25770886
[TBL] [Abstract][Full Text] [Related]
18. [Polish Multicenter Study on Diabetes Epidemiology (PMSDE)--1998-2000].
Szybiński Z
Pol Arch Med Wewn; 2001 Sep; 106(3):751-8. PubMed ID: 11928582
[TBL] [Abstract][Full Text] [Related]
19. Direct medical cost and glycemic control in type 2 diabetic Saudi patients.
Almutairi N; Alkharfy KM
Appl Health Econ Health Policy; 2013 Dec; 11(6):671-5. PubMed ID: 24174262
[TBL] [Abstract][Full Text] [Related]
20. The Association Between Poor Glycemic Control and Health Care Costs in People With Diabetes: A Population-Based Study.
Mata-Cases M; Rodríguez-Sánchez B; Mauricio D; Real J; Vlacho B; Franch-Nadal J; Oliva J
Diabetes Care; 2020 Apr; 43(4):751-758. PubMed ID: 32029636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
